During the COVID-19 pandemic, the Wellcome Centre for Human Genetics is taking measures to prevent the spread of the disease.
Departments are instructed by the University’s Registrar to continue to work from home where possible, and manage the return to on site working, based on the University guidelines for for risk assessments and work prioritisation.
The University remains open and operating as far as possible with the following restrictions:
- No public access to the University
- On-site activity permitted where it cannot be undertaken remotely, driven by safety, capacity and other factors such as schools reopening/other changes in government guidelines
- Teaching and assessment are undertaken remotely where possible and, depending on government guidelines, gatherings of staff and students only permitted where essential for teaching and assessment to take place
The Wellcome Centre for Human Genetics is a research institute of the Nuffield Department of Medicine at the University of Oxford, funded by the University, Wellcome and numerous other sponsors. It is based in purpose-built laboratories on the University of Oxford’s Biomedical Research Campus in Headington, one of the largest concentrations of biomedical expertise in the world.
With more than 400 active researchers and around 70 employed in administrative and support roles, the Centre is an international leader in genetics, genomics and structural biology.
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Alexander PG. et al, (2020), Br J Cancer
Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia
Moreira LM. et al, (2020), Nature, 587, 460 - 465
Genomic and transcriptomic correlates of Richter's transformation in Chronic Lymphocytic Leukemia.
Klintman J. et al, (2020), Blood
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff M. et al, (2020), Human Reproduction Update